18 0 2 0 2 B-lower_bound
years 3 8 3 8 I-lower_bound
or 9 11 9 11 O
older 12 17 12 17 O

> 0 1 18 19 O
2 1 2 19 20 B-lower_bound
inhalers 3 11 21 29 O
and 12 15 30 33 O
one 16 19 34 37 O
containing 20 30 38 48 O
steroids 31 39 49 57 B-treatment

AJCC 0 4 58 62 B-clinical_variable
stage 5 10 63 68 B-lower_bound
III 11 14 69 72 I-lower_bound
or 15 17 73 75 O
IV 18 20 76 78 B-upper_bound
completely 21 31 79 89 O
resectable 32 42 90 100 O
melanoma 43 51 101 109 B-cancer
identified 52 62 110 120 O
before 63 69 121 127 O
surgery 70 77 128 135 B-treatment

ALT 0 3 136 139 B-clinical_variable
and 4 7 140 143 O
AST 8 11 144 147 B-clinical_variable
≤ 12 13 148 149 O
1.5 14 17 150 153 B-upper_bound
ULN 18 21 154 157 I-upper_bound

ANC 0 3 158 161 B-clinical_variable
≥ 4 5 162 163 O
1,000 6 11 164 169 B-lower_bound
/ 11 12 169 170 I-lower_bound
μL 12 14 170 172 I-lower_bound

Active 0 6 173 179 O
pulmonary 7 16 180 189 B-chronic_disease
disease 17 24 190 197 I-chronic_disease
requiring 25 34 198 207 O
medication 35 45 208 218 B-treatment
to 46 48 219 221 O
include 49 56 222 229 O
multiple 57 65 230 238 B-treatment
inhalers 66 74 239 247 I-treatment

Clinically 0 10 248 258 O
disease 11 18 259 266 O
- 18 19 266 267 O
free 19 23 267 271 O
after 24 29 272 277 O
surgery 30 37 278 285 B-treatment

Completing 0 10 286 296 O
SoC 11 14 297 300 B-treatment
adjuvant 15 23 301 309 I-treatment
therapy 24 31 310 317 I-treatment
per 32 35 318 321 O
NCCN 36 40 322 326 O
guidelines 41 51 327 337 O
to 52 54 338 340 O
include 55 62 341 348 O
chemotherapy 63 75 349 361 B-treatment
, 75 76 361 362 O
radiation 77 86 363 372 B-treatment
therapy 87 94 373 380 I-treatment

Creatinine 0 10 381 391 B-clinical_variable
clearance 11 20 392 401 I-clinical_variable
≥ 21 22 402 403 O
50 23 25 404 406 B-lower_bound
% 25 26 406 407 I-lower_bound

Creatinine 0 10 408 418 B-clinical_variable
≤ 11 12 419 420 O
1.5 13 16 421 424 B-upper_bound
x 17 18 425 426 I-upper_bound
upper 19 24 427 432 I-upper_bound
limit 25 30 433 438 I-upper_bound
of 31 33 439 441 I-upper_bound
normal 34 40 442 448 I-upper_bound
( 41 42 449 450 I-upper_bound
ULN 42 45 450 453 I-upper_bound
) 45 46 453 454 I-upper_bound

ECOG 0 4 455 459 B-clinical_variable
> 5 6 460 461 O
2 6 7 461 462 B-lower_bound
performance 8 19 463 474 O
status 20 26 475 481 O
( 27 28 482 483 O
Appendix 28 36 483 491 O
D 37 38 492 493 O
) 38 39 493 494 O

Eastern 0 7 495 502 B-clinical_variable
Cooperative 8 19 503 514 I-clinical_variable
Oncology 20 28 515 523 I-clinical_variable
Group 29 34 524 529 I-clinical_variable
( 35 36 530 531 I-clinical_variable
ECOG 36 40 531 535 I-clinical_variable
) 40 41 535 536 I-clinical_variable
performance 42 53 537 548 I-clinical_variable
status 54 60 549 555 I-clinical_variable
0,1 61 64 556 559 B-lower_bound
( 65 66 560 561 O
Appendix 66 74 561 569 O
D 75 76 570 571 O
) 76 77 571 572 O

Evidence 0 8 573 581 O
of 9 11 582 584 O
residual 12 20 585 593 B-cancer
disease 21 28 594 601 I-cancer
after 29 34 602 607 O
surgery 35 42 608 615 B-treatment
and 43 46 616 619 O
SoC 47 50 620 623 O
adjuvant 51 59 624 632 B-treatment
therapies 60 69 633 642 I-treatment

For 0 3 643 646 O
women 4 9 647 652 B-gender
of 10 12 653 655 O
child 13 18 656 661 O
- 18 19 661 662 O
bearing 19 26 662 669 O
potential 27 36 670 679 O
, 36 37 679 680 O
agreement 38 47 681 690 B-contraception_consent
to 48 50 691 693 I-contraception_consent
use 51 54 694 697 I-contraception_consent
adequate 55 63 698 706 I-contraception_consent
birth 64 69 707 712 I-contraception_consent
control 70 77 713 720 I-contraception_consent
( 78 79 721 722 O
abstinence 79 89 722 732 B-contraception_consent
, 89 90 732 733 O
hysterectomy 91 103 734 746 B-contraception_consent
, 103 104 746 747 O
bilateral 105 114 748 757 B-contraception_consent
oophorectomy 115 127 758 770 I-contraception_consent
, 127 128 770 771 O
bilateral 129 138 772 781 B-contraception_consent
tubal 139 144 782 787 I-contraception_consent
ligation 145 153 788 796 I-contraception_consent
, 153 154 796 797 O
oral 155 159 798 802 B-contraception_consent
contraception 160 173 803 816 I-contraception_consent
, 173 174 816 817 O
IUD 175 178 818 821 B-contraception_consent
, 178 179 821 822 O
or 180 182 823 825 O
use 183 186 826 829 B-contraception_consent
of 187 189 830 832 I-contraception_consent
condoms 190 197 833 840 I-contraception_consent
or 198 200 841 843 I-contraception_consent
diaphragms 201 211 844 854 I-contraception_consent
) 211 212 854 855 O

Hgb 0 3 856 859 B-clinical_variable
≥ 4 5 860 861 O
9 6 7 862 863 B-lower_bound
g 8 9 864 865 I-lower_bound
/ 9 10 865 866 I-lower_bound
dL 10 12 866 868 I-lower_bound

Immune 0 6 869 875 B-chronic_disease
deficiency 7 17 876 886 I-chronic_disease
disease 18 25 887 894 I-chronic_disease
or 26 28 895 897 O
known 29 34 898 903 O
history 35 42 904 911 O
of 43 45 912 914 O
HIV 46 49 915 918 B-chronic_disease
, 49 50 918 919 O
HBV 51 54 920 923 B-chronic_disease
, 54 55 923 924 O
HCV 56 59 925 928 B-chronic_disease

Insufficient 0 12 929 941 O
tumor 13 18 942 947 B-cancer
available 19 28 948 957 O
to 29 31 958 960 O
produce 32 39 961 968 O
vaccine 40 47 969 976 O

Platelets 0 9 977 986 B-clinical_variable
≥ 10 11 987 988 O
75,000 12 18 989 995 B-lower_bound
/ 18 19 995 996 I-lower_bound
μL 19 21 996 998 I-lower_bound

Pregnancy 0 9 999 1008 B-pregnancy
( 10 11 1009 1010 O
assessed 11 19 1010 1018 O
by 20 22 1019 1021 O
urine 23 28 1022 1027 B-clinical_variable
HCG 29 32 1028 1031 I-clinical_variable
) 32 33 1031 1032 O

Receiving 0 9 1033 1042 O
immunosuppressive 10 27 1043 1060 B-treatment
therapy 28 35 1061 1068 I-treatment
including 36 45 1069 1078 O
chronic 46 53 1079 1086 B-treatment
steroids 54 62 1087 1095 I-treatment
, 62 63 1095 1096 O
methotrexate 64 76 1097 1109 B-treatment
, 76 77 1109 1110 O
or 78 80 1111 1113 O
other 81 86 1114 1119 O
known 87 92 1120 1125 O
immunosuppressive 93 110 1126 1143 B-treatment
agents 111 117 1144 1150 I-treatment

Total 0 5 1151 1156 O
bilirubin 6 15 1157 1166 B-clinical_variable
≤ 16 17 1167 1168 O
1.5 18 21 1169 1172 B-upper_bound
ULN 22 25 1173 1176 I-upper_bound

Vaccinations 0 12 1177 1189 B-treatment
initiated 13 22 1190 1199 O
between 23 30 1200 1207 O
3 31 32 1208 1209 B-lower_bound
weeks 33 38 1210 1215 I-lower_bound
and 39 42 1216 1219 O
3 43 44 1220 1221 B-upper_bound
months 45 51 1222 1228 I-upper_bound
from 52 56 1229 1233 O
completion 57 67 1234 1244 O
of 68 70 1245 1247 O
SoC 71 74 1248 1251 O
multi 75 80 1252 1257 O
- 80 81 1257 1258 O
modality 81 89 1258 1266 O
cancer 90 96 1267 1273 O
care 97 101 1274 1278 O

biologic 0 8 1279 1287 B-treatment
therapy 9 16 1288 1295 I-treatment
as 17 19 1296 1298 O
clinically 20 30 1299 1309 O
indicated 31 40 1310 1319 O

dispensable 0 11 1320 1331 O
tumor 12 17 1332 1337 B-cancer
that 18 22 1338 1342 O
will 23 27 1343 1347 O
not 28 31 1348 1351 O
interfere 32 41 1352 1361 O
with 42 46 1362 1366 O
pathologic 47 57 1367 1377 O
staging 58 65 1378 1385 O

